2020 SOHO Updates on Oral HMAs in MDS: Can FDA-Approved Decitabine/Cedazuridine (ASTX727) Combo Be Used as an Alternative to IV Decitabine? Does Oral CC-486 Maintenance Therapy Improve Survival?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

2020 SOHO Updates on Oral HMAs in MDS: Can FDA-Approved Decitabine/Cedazuridine (ASTX727) Combo Be Used as an Alternative to IV Decitabine? Does Oral CC-486 Maintenance Therapy Improve Survival?

By Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020) FEATURING Guillermo Garcia-Manero

154 views

November 9, 2020

SOHO 2020 on-demand content is available through January 12, 2021. To access the virtual environment, ...
read more ↘ resources and on-demand webinars, go to https://soho.click/register.
↖ read less

0 Comments

ASH 2023 Summary: "The Best of Acute Leukemia and MDS - Highlig…

Feat. T. Badar